Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2014

Jun 11, 2014

35274_dirs_2014-06-11_38915b45-36ee-4916-9bef-b488b5934620.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-06-11

Reporting Person: GARR RICHARD (Director, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-11 Common Stock G 12000 Disposed 1237337 Direct

Footnotes

F1: Disclosing a bonafide gift of 12,000 common shares.